Novo Nordisk (NYSE:NVO) and Eli Lilly (NYSE:LLY) shares fell more than 4% each in premarket trading on Friday following comments from President Trump a day earlier regarding potential price reductions ...

Influencers are promoting the weight-loss drug Retatrutide online, but it's an unapproved medication. Learn about the dangers ...

Back in May, a study was published suggesting that popular weight-loss drugs such as Ozempic and Wegovy could curb alcohol ...

Weight-loss surgery dramatically outperformed GLP-1 medications in improving longevity and reducing heart, kidney, and eye ...

Researchers found that older adults with diabetes who took semaglutide—a medicine sold under the brand names Ozempic and ...

Semaglutide, tirzepatide, and other GLP-1 drugs appear to slow alcohol absorption and blunt its intoxicating effects, ...

The criminal complaint says she “stated she was providing a service to women, her heart is good and all she does is give.” ...

Stocks ended higher Friday as investors shook off concerns about the health of the banking sector and mulled comments from ...

Janet McCaskill was on vacation in Arizona with her husband and best friend when she heard that President Donald Trump had ...

President Donald Trump said there will Ozempic prices will be lower after negotiations with Novo Nordisk as part of his ...

Eli Lilly stock dips after missing a priority voucher and price cut talks on rival obesity drugs. Read more here.

Novo Nordisk (NVO) stock is in focus as the company hires an executive from AbbVie (ABBV) as head of Corporate Affairs amid U ...